BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32065875)

  • 1. Development and validation of a radiomics signature on differentially expressed features of
    Cao Q; Li Y; Li Z; An D; Li B; Lin Q
    Radiother Oncol; 2020 May; 146():9-15. PubMed ID: 32065875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the Local Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemoradiotherapy by Radiomics with a Machine Learning Method Using
    Murakami Y; Kawahara D; Tani S; Kubo K; Katsuta T; Imano N; Takeuchi Y; Nishibuchi I; Saito A; Nagata Y
    Diagnostics (Basel); 2021 Jun; 11(6):. PubMed ID: 34200332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
    Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
    Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A machine learning approach using
    Qi WX; Li S; Xiao J; Li H; Chen J; Zhao S
    Front Immunol; 2024; 15():1351750. PubMed ID: 38352868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of pre-therapy
    Zhang J; Zhao X; Zhao Y; Zhang J; Zhang Z; Wang J; Wang Y; Dai M; Han J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1137-1146. PubMed ID: 31728587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an
    Wang H; Zhao S; Li L; Tian R
    Eur Radiol; 2020 Oct; 30(10):5578-5587. PubMed ID: 32435928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
    Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
    BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
    Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
    Front Oncol; 2020; 10():1398. PubMed ID: 32850451
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Huang K; Huang X; Zeng C; Wang S; Zhan Y; Cai Q; Peng G; Yang Z; Zhou L; Chen J; Chen C
    Cancer Imaging; 2024 Apr; 24(1):54. PubMed ID: 38654284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cone-beam computed-tomography-based delta-radiomic analysis for investigating prognostic power for esophageal squamous cell cancer patients undergoing concurrent chemoradiotherapy.
    Nakamoto T; Yamashita H; Jinnouchi H; Nawa K; Imae T; Takenaka S; Aoki A; Ohta T; Ozaki S; Nozawa Y; Nakagawa K
    Phys Med; 2024 Jan; 117():103182. PubMed ID: 38086310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
    Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
    Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
    Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-radiochemotherapy PET radiomics in head and neck cancer - The influence of radiomics implementation on the reproducibility of local control tumor models.
    Bogowicz M; Leijenaar RTH; Tanadini-Lang S; Riesterer O; Pruschy M; Studer G; Unkelbach J; Guckenberger M; Konukoglu E; Lambin P
    Radiother Oncol; 2017 Dec; 125(3):385-391. PubMed ID: 29122358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiation.
    Li Y; Beck M; Päßler T; Lili C; Hua W; Mai HD; Amthauer H; Biebl M; Thuss-Patience PC; Berger J; Stromberger C; Tinhofer I; Kruppa J; Budach V; Hofheinz F; Lin Q; Zschaeck S
    Sci Rep; 2020 Oct; 10(1):17671. PubMed ID: 33077841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Cui Y; Yang X; Shi Z; Yang Z; Du X; Zhao Z; Cheng X
    Eur Radiol; 2019 Mar; 29(3):1211-1220. PubMed ID: 30128616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response Prediction to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Delta-Radiomics Based on Sequential Whole-Tumor ADC Map.
    An D; Cao Q; Su N; Li W; Li Z; Liu Y; Zhang Y; Li B
    Front Oncol; 2022; 12():787489. PubMed ID: 35392222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics models based on CT at different phases predicting lymph node metastasis of esophageal squamous cell carcinoma (GASTO-1089).
    Peng G; Zhan Y; Wu Y; Zeng C; Wang S; Guo L; Liu W; Luo L; Wang R; Huang K; Huang B; Chen J; Chen C
    Front Oncol; 2022; 12():988859. PubMed ID: 36387160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-based radiomics value for predicting the survival of patients with locally advanced cervical squamous cell cancer treated with concurrent chemoradiotherapy.
    Zhang X; Zhao J; Zhang Q; Wang S; Zhang J; An J; Xie L; Yu X; Zhao X
    Cancer Imaging; 2022 Jul; 22(1):35. PubMed ID: 35842679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CT-based radiomics analysis for evaluating the differentiation degree of esophageal squamous carcinoma].
    Cheng L; Wu L; Chen S; Ye W; Liu Z; Liang C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 44(3):251-256. PubMed ID: 30971516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.